MYCO-B ONE DOSE
  • UPDATE: NEW FEEDLOT STUDY
    • Study Detailer
    • Study Overview
    • Study Paper
  • Home
  • About M. bovis
    • M. bovis global reach
    • About Mycoplasma bovis
    • About M. bovis con'td
  • Product Insert
  • Studies
    • Why MYCO-B ONE DOSE?
    • Respiratory Studies
    • Arthritis Studies
    • 2018 Feedlot Study
    • NEW: 2019 Feedlot Study
  • Where to Buy
  • Contact Us

Efficacy of a single dose Mycoplasma bovis vaccine on the performance
and health of high risk beef cattle in a commercial feedlot.

C. Stevens, L. Taylor, J. Valles, M. Fruge and D.U. Thomson, Production Animal Consultation Research 

Bovine respiratory disease is the most common cause of death in feedlot cattle. Viral and bacterial pathogens have been identified as being     primary or secondary causes of this deadly disease. Over the last 20 years, Mycoplasma bovis has been described as a pathogen of interest in          acute and chronic BRD cases. Commercial and autogenous Mycoplasma bovis vaccines have been developed to immunize cattle from this pathogen. The objective of this study was to identify any differences in performance and animal health in lightweight, high health risk calves, vaccinated with      a single dose of Mycoplasma vaccine [MYCO-B ONE DOSE (TM) AAH, Inc.] compared to similar calves that were not vaccinated.
Picture

Product Info...
Picture
© COPYRIGHT 2016. American Animal Health, Inc.;  
​Grand Prairie, TX 75052 USA; ​ ALL RIGHTS RESERVED.
  • UPDATE: NEW FEEDLOT STUDY
    • Study Detailer
    • Study Overview
    • Study Paper
  • Home
  • About M. bovis
    • M. bovis global reach
    • About Mycoplasma bovis
    • About M. bovis con'td
  • Product Insert
  • Studies
    • Why MYCO-B ONE DOSE?
    • Respiratory Studies
    • Arthritis Studies
    • 2018 Feedlot Study
    • NEW: 2019 Feedlot Study
  • Where to Buy
  • Contact Us